PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunobiology, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA.\', \'Yale University School of Medicine, New Haven, CT, USA.\', \'Yale University School of Medicine, New Haven, CT, USA; Department of Cardiac Surgery, Yale New Haven Hospital, New Haven, CT, USA.\', \'Yale University School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.\', \'Department of Immunobiology, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. Electronic address: akiko.iwasaki@yale.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1473-3099(21)00472-210.1016/S1473-3099(21)00472-2
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34534512
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Prevention of host-to-host transmission by SARS-CoV-2 vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all